BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29452556)

  • 1. Use of a Prescription-Assistance Program for Medically Uninsured Patients With Cancer: Case Study of a Public Hospital Experience in New York State.
    Gao L; Joseph J; Santoro-Levy M; Gotlieb VK; Multz AS
    J Oncol Pract; 2014 Mar; 10(2):104. PubMed ID: 29452556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.
    Gao L; Joseph J; Santoro-Levy M; Multz AS; Gotlieb VK
    Hosp Pharm; 2016 Jul; 51(7):572-6. PubMed ID: 27559190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
    Clay P; Vaught E; Glaros A; Mangum S; Hansen D; Lindsey C
    J Manag Care Pharm; 2007; 13(6):506-14. PubMed ID: 17672812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Program for procurement of drugs for indigent patients.
    Decane BE; Chapman J
    Am J Hosp Pharm; 1994 Mar; 51(5):669-71. PubMed ID: 8203387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing an on-site pharmacy in a community health center to help indigent patients access medications and to improve care.
    Dent LA; Stratton TP; Cochran GA
    J Am Pharm Assoc (Wash); 2002; 42(3):497-507. PubMed ID: 12030637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S13-7. PubMed ID: 17057055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic.
    Chisholm MA; Vollenweider LJ; Mulloy LL; Wynn JJ; Wade WE; DiPiro JT
    Clin Transplant; 2000 Aug; 14(4 Pt 1):304-7. PubMed ID: 10945200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization.
    Burley MH; Daratha KB; Tuttle K; White JR; Wilson M; Armstrong K; McPherson S; Selinger S
    J Manag Care Spec Pharm; 2016 Apr; 22(4):381-7. PubMed ID: 27023691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center.
    Felder TM; Lal LS; Bennett CL; Hung F; Franzini L
    Community Oncol; 2011 Jun; 8(6):279-286. PubMed ID: 22879815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost.
    Castellon YM; Bazargan-Hejazi S; Masatsugu M; Contreras R
    Am J Manag Care; 2014 Feb; 20(2):146-50. PubMed ID: 24738532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of Leveraging Pharmaceutical Patient Assistance Programs to Expand Access to High Cost Medications in a Student-Run Free Clinic.
    Lee JJ; Sack DE; Kam S; Reed SC; Carew B; Lloyd C; Weaver EO; Miller RF
    J Community Health; 2023 Dec; 48(6):919-925. PubMed ID: 37284916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics.
    Mitchell A; Muluneh B; Patel R; Basch E
    J Oncol Pharm Pract; 2018 Sep; 24(6):424-432. PubMed ID: 28714357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managed care for uninsured adults: the rise and fall of a university-based program.
    Steiner JF; Price DW; Chandramouli V; Goodspeed JR
    Am J Manag Care; 2002 Jul; 8(7):653-61. PubMed ID: 12125805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost savings analysis of prescription assistance programs at a student-run free clinic.
    Chow N; Snitman A; Rafael J; Bui S; Bennett K; Prabhu F
    Proc (Bayl Univ Med Cent); 2022; 35(3):319-321. PubMed ID: 35518798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical manufacturer assistance programs.
    Chisholm MA; DiPiro JT
    Arch Intern Med; 2002 Apr; 162(7):780-4. PubMed ID: 11926851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a pharmacist-run call center on medication access for ambulatory care patients.
    Bartlett D; Evans P; Sullivan M
    Am J Health Syst Pharm; 2009 Sep; 66(18):1666-8. PubMed ID: 19729572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The University of North Carolina's Health Care Pharmacy Assistance Progam.
    Crisp GD; Roberts AW; Esserman DA; Roth MT; Weinberger M; Farley JF
    N C Med J; 2014; 75(5):303-9. PubMed ID: 25237867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a patient medication assistance program in a community pharmacy setting.
    Mounts VL; Ringenberg DG; Rhees K; Partridge C
    J Am Pharm Assoc (2003); 2005; 45(1):76-81. PubMed ID: 15730120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program.
    Weiner S; Dischler J; Horvitz C
    Am J Health Syst Pharm; 2001 Jan; 58(2):146-50. PubMed ID: 11202538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication assistance programs for uninsured and indigent patients.
    Chisholm MA; Reinhardt BO; Vollenweider LJ; Kendrick BD; DiPiro JT
    Am J Health Syst Pharm; 2000 Jun; 57(12):1131-6. PubMed ID: 10911511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.